Skip to main content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation
Med Hypotheses. 2020 Nov; 144: 110031.
Published online 2020 Jun 24. doi: 10.1016/j.mehy.2020.110031
PMCID: PMC7313523
PMID: 33254479

Are graphene and graphene-derived products capable of preventing COVID-19 infection?

Associated Data

Supplementary Materials

Abstract

The Severe Acute Respiratory Syndrome CoronaVirus 2 (SARS-CoV-2) causes the new coronavirus disease 2019 (COVID-19). This disease is a severe respiratory tract infection that spreading rapidly around the world. In this pandemic situation, the researchers' effort is to understand the targets of the virus, mechanism of their cause, and transmission from animal to human and vice-versa. Therefore, to support COVID-19 research and development, we have proposed approaches based on graphene and graphene-derived nanomaterials against COVID-19.

Keywords: Graphene, Graphene oxide, Reduced graphene oxide, COVID-19, SARS-CoV-2, ACE2

Introduction

The entry of SARS-CoV-2 in human relies on its Spike-protein (S-protein) interaction with human Angiotensin-Converting Enzyme 2 (ACE2), a human cell surface receptor that facilitates viral entry and replication, which is similar in pathogenesis to that of SARS-CoV [1]. The advancement of nano-based antiviral agents gained the popularity to be used for the treatment of COVID-19 [2]. Several studies have used immunomodulator proteins encapsulated nanoparticles against SARS-CoV, which can also be assessed to eradicate SARS-CoV-2 [3], [4]. Graphene and graphene-derived (graphene oxide (GO), reduced graphene oxide (rGO), and graphene quantum dots (GQDs)) nanomaterials have wide biomedical applications. Graphene is a hydrophobic material, and its two-dimensional structure represents a sheet of sp2-hybridized carbon atoms [5]. In contrast, the GO is hydrophilic in nature and has electronic properties [6]. The reduction of GO through the thermal process produces rGO, which is a highly hydrophilic material with lesser oxygen content [7]. Besides, in stacked graphene, the layers stick together on top of each other through π-π-stacking interactions [8]. However, this spacing is significantly increased due to intercalated oxygen groups in the interlayers of GO and rGO [9]. Interestingly, these graphene and graphene-derived nanomaterials have both antimicrobial and antiviral efficiency [10], [11], [12]. The antibacterial properties of graphene [13], and graphene-derivatives [14], [15], are mainly because of their electron movement towards bacteria. This migration causes cytoplasmic efflux, decreases metabolism, affects lipid membrane, induces oxidative stress, produces reactive oxygen species (ROS), loss of glutathione, and finally causes bacterial death [16]. It has been reported that lipid bilayer of feline coronavirus is adsorbed on the surface of GO and rGO through hydrogen bonding and electrostatic interactions [17]. Among graphene-derived materials, GO has the highest negative charge, which can have a higher affinity for positively charged viruses. Subsequently, the binding of these graphene-derived materials destroyed the viral membrane [18], [19], and confirmed the GO efficacy against viruses [20]. However, the graphene surface can also be modified by conjugating with the negatively charged antivirals such as heparin, drugs, and heparan sulfate [21], [22]. This increases the modified graphene affinity with positively charged residues of the viruses, which has been used to develop a diagnostic or therapeutic product [23]. Similarly, rGO modified with sulfate derivatives effectively exterminate herpesvirus strains, swine fever, and orthopoxvirus [24]. Recently, a company, Bonbouton developed an economical and reusable graphene mask [25]. Another company, Zen Graphene Solutions Ltd. has proposed a composite ink of GO and silver nanoparticles that effectively eradicates other strains of coronavirus [26]. Moreover, a graphene-based air purification technology is under-development that could help to kill coronaviruses [27]. Thus, identification and development of possible treatments and approaches are required globally, either to block S-protein or to eradicate the SARS-CoV-2.

Central principle

To emphasize the molecular mechanism underlying the interaction between S-protein and nanoelectromechanical materials such as graphene and graphene-derivatives (GO, rGO, and GQDs) to block SARS-CoV-2 interaction with human ACE2.

Hypothesis and conclusion

Owing to electroconductive properties, graphene and its derivatives can interact with several biomolecules, translocate within the endosome or lysosome, cross the plasma membrane, and regulates mitochondrion, nucleus, and the cytoskeleton. Notably, the hydrophobicity of graphene increases with an increased number of graphene layers [28]. Therefore, considering all these features, we have suggested a potential graphene-based therapeutic approach, and to determine whether it can be virucidal, it would likely be proven as an economical and efficient treatment against COVID-19 (Fig. 1 ). Primarily, the affinity and stability of single and multilayer graphene and graphene-derived nanomaterials for SARS-CoV-2 can be computationally elucidated using docking and molecular dynamics (MD) simulations studies, respectively. Afterward, the findings can be verified using molecular and cell biology assays to determine the associations compared to SARS-CoV-2 and ACE2 complex (control). The mono or multi layered graphene and graphene-derivatives can be used as products in the form of mist spray to block the entry of coronaviruses or can be applied to fabrics for substantially enhanced protection. Therefore, personal protective equipment (PPE) should be coated with increased layers of graphene or graphene-derived materials to keep PPE dry that will prevent or repel the aerosol transmission of SARS-CoV-2. All these graphene-based composites would likely be facilitated to combat against the COVID-19 pandemic. The information comprised in this perspective provides a hypothetical approach that would likely help in preventing COVID-19 infection using graphene-based products. Several products can be developed by considering the electroconductive and hydrophobic properties of graphene and graphene-derived nanomaterials, or their affinity with SARS-CoV-2. GO and silver nanoparticles composite conjugated with antivirals can potentially trap and kill SARS-CoV-2. The mist spray can be used to clean any object's surface and for human body sanitization. However, it can also be used as a nasal or mouth spray to block/mask the S-protein of SARS-CoV-2 substantially. Also, surface cleaner wipes coated with graphene or graphene-derived nanomaterials can be a better option to disinfect the infected area. The graphene-based nano-drugs conjugated with antivirals can be an effective and successful formulation. Reusable PPE coated with modified nanomaterials with enhanced capacity to repel the SARS-CoV-2 is necessarily required to prevent aerosol transmission in medical healthcare workers. The SARS-CoV-2 present in the environment can be filtered by introducing the multiple layer nanomaterials with modified positive charge filters in the air purification and air-conditioning devices, capable of killing SARS-CoV-2.

An external file that holds a picture, illustration, etc.
Object name is gr1_lrg.jpg

Schematic representation of graphene, and graphene-derived nanomaterials interaction with SARS-CoV-2 and their applications. The identification of association (binding) or dissociation (repelling) capability of nanomaterials with SARS-CoV-2 can be verified primarily computationally and then experimentally. The interaction analysis helps to decide the development of the product such as nanoparticles, mist spray, surface cleaning wipes, nano-drugs, PPE (Personal Protection Equipment), or air filters. SARS-CoV-2 image source: https://phil.cdc.gov//PHIL_Images/23311/23311.tif.

Acknowledgements

We acknowledge the support from All India Institute of Medical Sciences (AIIMS), New Delhi  & Department of Biotechnology (DBT), Ministry of Science & Technology, Government of India (grant no. BT/01/COE/07/03).

Conflict of interest

The authors declare no conflict of interest.

Author contributions

PKR and SM designed research; PKR analyzed data; PKR and SM performed research; PKR searched and read the articles; PKR prepared the figure; PKR and SM wrote the paper.

Footnotes

Appendix ASupplementary data to this article can be found online at https://doi.org/10.1016/j.mehy.2020.110031.

Appendix A. Supplementary data

The following are the Supplementary data to this article:

Supplementary data 1:
Click here to view.(221 bytes, xml)

References

1. Hanff T.C., Harhay M.O., Brown T.S., Cohen J.B., Mohareb A.M. Is there an association between COVID-19 mortality and the renin-angiotensin system-a call for epidemiologic investigations. Clin Infect Dis. 2020 doi: 10.1093/cid/ciaa329. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
2. Khan S., Siddique R., Shereen M.A., Ali A., Liu J., Bai Q. The emergence of a novel coronavirus (SARS-CoV-2), their biology and therapeutic options. J Clin Microbiol. 2020 doi: 10.1128/JCM.00187-20. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
3. Wohlford-Lenane C.L., Meyerholz D.K., Perlman S., Zhou H., Tran D., Selsted M.E. Rhesus theta-defensin prevents death in a mouse model of severe acute respiratory syndrome coronavirus pulmonary disease. J Virol. 2009 doi: 10.1128/jvi.01363-09. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
4. Wiley J.A., Richert L.E., Swain S.D., Harmsen A., Barnard D.L., Randall T.D. Inducible bronchus-associated lymphoid tissue elicited by a protein cage nanoparticle enhances protection in mice against diverse respiratory viruses. PLoS One. 2009 doi: 10.1371/journal.pone.0007142. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
5. Banerjee A.N. Graphene and its derivatives as biomedical materials: Future prospects and challenges. Interface Focus. 2018 doi: 10.1098/rsfs.2017.0056. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
6. Hummers W.S., Offeman R.E. Preparation of graphitic oxide. J Am Chem Soc. 1958 doi: 10.1021/ja01539a017. [CrossRef] [Google Scholar]
7. Pei S., Cheng H.M. The reduction of graphene oxide. Carbon N Y. 2012 doi: 10.1016/j.carbon.2011.11.010. [CrossRef] [Google Scholar]
8. Eigler S., Hirsch A. Chemistry with graphene and graphene oxide – Challenges for synthetic chemists. Angew Chemie - Int Ed. 2014 doi: 10.1002/anie.201402780. [PubMed] [CrossRef] [Google Scholar]
9. Sheng Y., Tang X., Peng E., Xue J. Graphene oxide based fluorescent nanocomposites for cellular imaging. J Mater Chem B. 2013 doi: 10.1039/c2tb00123c. [PubMed] [CrossRef] [Google Scholar]
10. Akhavan O., Choobtashani M., Ghaderi E. Protein degradation and RNA efflux of viruses photocatalyzed by graphene-tungsten oxide composite under visible light irradiation. J Phys Chem C. 2012 doi: 10.1021/jp301707m. [CrossRef] [Google Scholar]
11. Palmieri V., Papi M. Can graphene take part in the fight against COVID-19? Nano Today. 2020 doi: 10.1016/j.nantod.2020.100883. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
12. Bhattacharjee S., Joshi R., Chughtai A.A., Macintyre C.R. Graphene Modified Multifunctional Personal Protective Clothing. Adv Mater Interfaces. 2019 doi: 10.1002/admi.201900622. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
13. Hu W., Peng C., Luo W., Lv M., Li X., Li D. Graphene-based antibacterial paper. ACS Nano. 2010 doi: 10.1021/nn101097v. [PubMed] [CrossRef] [Google Scholar]
14. Han W., Wu Z., Li Y., Wang Y. Graphene family nanomaterials (GFNs)—promising materials for antimicrobial coating and film: A review. Chem Eng J. 2019 doi: 10.1016/j.cej.2018.10.106. [CrossRef] [Google Scholar]
15. Zhao J., Deng B., Lv M., Li J., Zhang Y., Jiang H. Graphene oxide-based antibacterial cotton fabrics. Adv Healthc Mater. 2013 doi: 10.1002/adhm.201200437. [PubMed] [CrossRef] [Google Scholar]
16. Ji H., Sun H., Qu X. Antibacterial applications of graphene-based nanomaterials: Recent achievements and challenges. Adv Drug Deliv Rev. 2016 doi: 10.1016/j.addr.2016.04.009. [PubMed] [CrossRef] [Google Scholar]
17. Song Z., Wang X., Zhu G., Nian Q., Zhou H., Yang D. Virus capture and destruction by label-free graphene oxide for detection and disinfection applications. Small. 2015 doi: 10.1002/smll.201401706. [PubMed] [CrossRef] [Google Scholar]
18. Rui L., Liu J., Li J., Weng Y., Dou Y., Yuan B. Reduced graphene oxide directed self-assembly of phospholipid monolayers in liquid and gel phases. Biochim Biophys Acta – Biomembr. 2015 doi: 10.1016/j.bbamem.2015.02.018. [PubMed] [CrossRef] [Google Scholar]
19. Frost R., Jönsson G.E., Chakarov D., Svedhem S., Kasemo B. Graphene oxide and lipid membranes: Interactions and nanocomposite structures. Nano Lett. 2012 doi: 10.1021/nl203107k. [PubMed] [CrossRef] [Google Scholar]
20. Chen Y.N., Hsueh Y.H., Te H.C., Tzou D.Y., Chang P.L. Antiviral activity of graphene–silver nanocomposites against non-enveloped and enveloped viruses. Int J Environ Res Public Health. 2016 doi: 10.3390/ijerph13040430. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
21. Naskalska A., Dabrowska A., Szczepanski A., Milewska A., Jasik K.P., Pyrc K. Membrane protein of Human coronavirus NL63 Is responsible for interaction with the adhesion receptor. J Virol. 2019 doi: 10.1128/jvi.00355-19. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
22. Jones S.T., Cagno V., Janeček M., Ortiz D., Gasilova N., Piret J. Modified cyclodextrins as broad-spectrum antivirals. Sci Adv. 2020 doi: 10.1126/sciadv.aax9318. [PMC free article] [PubMed] [CrossRef] [Google Scholar]
23. Ziem B., Azab W., Gholami M.F., Rabe J.P., Osterrieder N., Haag R. Size-dependent inhibition of herpesvirus cellular entry by polyvalent nanoarchitectures. Nanoscale. 2017 doi: 10.1039/c7nr00611j. [PubMed] [CrossRef] [Google Scholar]
24. Ziem B., Thien H., Achazi K., Yue C., Stern D., Silberreis K. Highly efficient multivalent 2D nanosystems for inhibition of orthopoxvirus particles. Adv Healthc Mater. 2016 doi: 10.1002/adhm.201600812. [PubMed] [CrossRef] [Google Scholar]
25. https://www.bonbouton.com/covid-mask.
26. https://www.mining.com/graphene-ink-may-be-used-to-fight-novel-coronavirus/.
27. https://www.graphene-info.com/.
28. Munz M., Giusca C.E., Myers-Ward R.L., Gaskill D.K., Kazakova O. Thickness-dependent hydrophobicity of epitaxial graphene. ACS Nano. 2015 doi: 10.1021/acsnano.5b03220. [PubMed] [CrossRef] [Google Scholar]

Articles from Medical Hypotheses are provided here courtesy of Elsevier

-